Andrew Miller
Login to view DISC.Dr. Andrew Miller is a highly accomplished biopharmaceutical executive who founded Karuna Therapeutics and invented COBENFY (KarXT), the first new class of schizophrenia treatment in decades. A PhD graduate from MIT, he is now Chairman of the Board at Progentos Therapeutics, which focuses on therapies for Multiple Sclerosis.
Outside of his direct research, Dr. Miller is passionate about fostering innovation in mental health. He actively supports and mentors startups in the field through his work with accelerator programs like One Mind. He recently had the honor of attending the TIME100 Next Gala and walking his first red carpet.
Unique fact: To create the groundbreaking drug COBENFY, he tested over 7, 000 compounds, ultimately finding success with an "out-of-the-box approach" that combined a psychiatric drug with a treatment for overactive bladders.
Read the full overview →How Andrew shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Andrew cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.